1. Euryachincoside, a Novel Phenolic Glycoside with Anti-Hepatic Fibrosis Activity from Eurya chinensis.
- Author
-
Li, Bai-Lin, Liang, Hui-Jun, Li, Qian-Ran, Wang, Qian, Ao, Zhuo-Yi, Fan, Yu-Wen, Zhang, Wei-Jie, Lian, Xin, Chen, Jia-Yan, Yuan, Jie, and Wu, Jie-Wei
- Subjects
IN vitro studies ,TRANSFORMING growth factors-beta ,CYTOKINES ,COLLAGEN ,IN vivo studies ,ANIMAL experimentation ,NUCLEAR factor E2 related factor ,GLYCOSIDES ,FIBROSIS ,NUCLEAR magnetic resonance spectroscopy ,NF-kappa B ,TRADITIONAL medicine ,CELLULAR signal transduction ,TREATMENT effectiveness ,RESEARCH funding ,PLANT extracts ,CELL surface antigens ,MICE ,IMMUNODIAGNOSIS - Abstract
Eurya chinensis has been recorded as a folk medicine traditionally used for treatment of a variety of symptoms. However, the phytochemical and pharmacological investigations of this plant are still scarce. A novel phenolic glycoside named Euryachincoside (ECS) was isolated by chromatographic separation from E. chinensis, and its chemical structure was identified by analysis of HRMS and NMR data. Its anti-hepatic fibrosis effects were evaluated in both HSC-T6 (rat hepatic stellate cells) and carbon tetrachloride (CCl
4 )-induced mice with Silybin (SLB) as the positive control. In an in vitro study, ECS showed little cytotoxicity and inhibited transforming growth factor-beta (TGF- β)-induced Collagen I (Col1) along with alpha-smooth muscle actin (α -SMA) expressions in HSC-T6. An in vivo study suggested ECS significantly ameliorated hepatic injury, secretions of inflammatory cytokines, and collagen depositions. Moreover, ECS markedly mediated Smad2/3, nuclear factor kappa B (NF- κ B) and nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathways both in vitro and vivo. These present findings confirmed that ECS is a novel phenolic glycoside from E. chinensis with promising curative effects on hepatic fibrosis, and its mechanisms may include decreasing extracellular matrix accumulation, reducing inflammation and attenuating free radicals via Smad2/3, NF- κ B and Nrf2 signaling pathways, which may shed light on the exploration of more effective phenolic glycoside-based anti-fibrotic agents. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF